Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis (Q36713605)

15 August 2017

Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis (English)

1 reference

15 August 2017

Ruth Holm

1

1 reference

15 August 2017

Gregg Van de Putte

2

1 reference

15 August 2017

Zhenhe Suo

3

1 reference

15 August 2017

A Kathrine Lie

4

1 reference

15 August 2017

Gunnar B Kristensen

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

5 June 2008

1 reference

International Journal of Medical Sciences

15 August 2017

1 reference

15 August 2017

5

1 reference

15 August 2017

3

1 reference

15 August 2017

121-126

1 reference

Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

EphA2 overexpression is associated with angiogenesis in ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Patterns of EphA2 protein expression in primary and metastatic pancreatic carcinoma and correlation with genetic status

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

EPHA2/EFNA1 expression in human gastric cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

EphA2 expression is associated with aggressive features in ovarian carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Eph receptors and ephrins: effectors of morphogenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Expression of two novel eph-related receptor protein tyrosine kinases in mammary gland development and carcinogenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

EphA2 overexpression causes tumorigenesis of mammary epithelial cells.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Overexpression of the EphA2 tyrosine kinase in prostate cancer.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Prognostic significance of parametrial extension in patients with cervical carcinoma Stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Carcinoma of the cervix uteri

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424178

Cyclins and proliferation markers in early squamous cervical carcinoma

20 October 2018

1 reference

12 December 2020

Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy

1 reference

12 December 2020

Prognostic factors of early stage cervical cancer treated by radical hysterectomy

1 reference

12 December 2020

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

1 reference

12 December 2020

Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis

1 reference

12 December 2020

Identifiers

DOI

10.7150/IJMS.5.121

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

18566674

1 reference